Stock Chart

HLN

$8.80 +0.92%
Score: 30.7 AVOID NEW MONEY
Pro
Screener
Vol: 1.03x (vs SPY: 1.0x | vs QQQ: 1.0x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 02, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About HLN - Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are …

Key Statistics

Market Cap $38B
P/E Ratio 18.17
Dividend Yield 0.02%

This HLN stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track HLN's price movements with trendlines, gamma walls, and key support/resistance levels.